| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | OSTX | Common stock, par value $0.001 per share | 200,000 | 31 Jul 2024 | Direct |
Robert Petit is the Chief Medical Officer and Chief Scientific Officer of OS Therapies Incorporated.